199 related articles for article (PubMed ID: 21815061)
1. Neurospheres as a model for developmental neurotoxicity testing.
Fritsche E; Gassmann K; Schreiber T
Methods Mol Biol; 2011; 758():99-114. PubMed ID: 21815061
[TBL] [Abstract][Full Text] [Related]
2. Neural stem cells for developmental neurotoxicity studies.
Tofighi R; Moors M; Bose R; Ibrahim WN; Ceccatelli S
Methods Mol Biol; 2011; 758():67-80. PubMed ID: 21815059
[TBL] [Abstract][Full Text] [Related]
3. Automated neurosphere sorting and plating by the COPAS large particle sorter is a suitable method for high-throughput 3D in vitro applications.
Gassmann K; Baumann J; Giersiefer S; Schuwald J; Schreiber T; Merk HF; Fritsche E
Toxicol In Vitro; 2012 Sep; 26(6):993-1000. PubMed ID: 22579513
[TBL] [Abstract][Full Text] [Related]
4. Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events.
Baumann J; Gassmann K; Masjosthusmann S; DeBoer D; Bendt F; Giersiefer S; Fritsche E
Arch Toxicol; 2016 Jun; 90(6):1415-27. PubMed ID: 26216354
[TBL] [Abstract][Full Text] [Related]
5. The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro.
Hayess K; Riebeling C; Pirow R; Steinfath M; Sittner D; Slawik B; Luch A; Seiler AE
Toxicology; 2013 Dec; 314(1):135-47. PubMed ID: 24096155
[TBL] [Abstract][Full Text] [Related]
6. Omnisphero: a high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro.
Schmuck MR; Temme T; Dach K; de Boer D; Barenys M; Bendt F; Mosig A; Fritsche E
Arch Toxicol; 2017 Apr; 91(4):2017-2028. PubMed ID: 27722930
[TBL] [Abstract][Full Text] [Related]
7. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing.
Moors M; Rockel TD; Abel J; Cline JE; Gassmann K; Schreiber T; Schuwald J; Weinmann N; Fritsche E
Environ Health Perspect; 2009 Jul; 117(7):1131-8. PubMed ID: 19654924
[TBL] [Abstract][Full Text] [Related]
8. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints.
Bal-Price AK; Hogberg HT; Buzanska L; Lenas P; van Vliet E; Hartung T
Neurotoxicology; 2010 Sep; 31(5):545-54. PubMed ID: 19969020
[TBL] [Abstract][Full Text] [Related]
9. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach.
Hogberg HT; Kinsner-Ovaskainen A; Coecke S; Hartung T; Bal-Price AK
Toxicol Sci; 2010 Jan; 113(1):95-115. PubMed ID: 19651682
[TBL] [Abstract][Full Text] [Related]
10. Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity.
Stern M; Gierse A; Tan S; Bicker G
Arch Toxicol; 2014 Jan; 88(1):127-36. PubMed ID: 23917397
[TBL] [Abstract][Full Text] [Related]
11. Development of the Concept for Stem Cell-Based Developmental Neurotoxicity Evaluation.
Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
Toxicol Sci; 2018 Sep; 165(1):14-20. PubMed ID: 29982725
[TBL] [Abstract][Full Text] [Related]
12. Culture of human neurospheres in 3D scaffolds for developmental neurotoxicity testing.
Hellwig C; Barenys M; Baumann J; Gassmann K; Casanellas L; Kauer G; Fritsche E
Toxicol In Vitro; 2018 Oct; 52():106-115. PubMed ID: 29883730
[TBL] [Abstract][Full Text] [Related]
13. Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat cortical neurons.
Hogberg HT; Sobanski T; Novellino A; Whelan M; Weiss DG; Bal-Price AK
Neurotoxicology; 2011 Jan; 32(1):158-68. PubMed ID: 21056592
[TBL] [Abstract][Full Text] [Related]
14. Don't judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing.
de Groot MW; Westerink RH; Dingemans MM
Toxicol Sci; 2013 Mar; 132(1):1-7. PubMed ID: 22961093
[TBL] [Abstract][Full Text] [Related]
15. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
[TBL] [Abstract][Full Text] [Related]
16. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of adult neural stem cells.
Siebzehnrubl FA; Vedam-Mai V; Azari H; Reynolds BA; Deleyrolle LP
Methods Mol Biol; 2011; 750():61-77. PubMed ID: 21618083
[TBL] [Abstract][Full Text] [Related]
18. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
Li J; Settivari R; LeBaron MJ; Marty MS
Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
[TBL] [Abstract][Full Text] [Related]
19. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity comparison of 35 developmental neurotoxicants in human induced pluripotent stem cells (iPSC), iPSC-derived neural progenitor cells, and transformed cell lines.
Kamata S; Hashiyama R; Hana-Ika H; Ohkubo I; Saito R; Honda A; Anan Y; Akahoshi N; Noguchi K; Kanda Y; Ishii I
Toxicol In Vitro; 2020 Dec; 69():104999. PubMed ID: 32949729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
